Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
Am J Kidney Dis. 2021 Sep;78(3):459-463. doi: 10.1053/j.ajkd.2021.01.014. Epub 2021 Mar 25.
There is increasing recognition of monoclonal gammopathy as a cause of proliferative glomerulonephritis (GN), including cases in which glomerular deposition of monoclonal immunoglobulin is demonstrated. Recently, proliferative GN with monoclonal immunoglobulin deposits (PGNMID) has incorporated a light chain variant of the disease (termed PGNMID-LC). Intriguingly, glomerular co-deposition of C3 is found in addition to monotypic light chain, implying complement activation via the alternative pathway (AP). We present a unique case of proliferative GN in a 42-year-old man who presented with nephrotic syndrome and was found to have κ light chain multiple myeloma. Immune staining of the glomerulus was positive only for κ light chain and C3, with the striking appearance of nonamyloid fibrils on electron microscopy. Following clonally targeted therapy for myeloma, the renal clinical abnormalities resolved completely. We present detailed molecular studies for light chain and complement and consider local mechanisms whereby monoclonal κ light chain fibrils may have triggered AP activation within the glomerulus.
越来越多的人认识到单克隆丙种球蛋白血症是增生性肾小球肾炎(GN)的一个原因,包括证明肾小球内单克隆免疫球蛋白沉积的病例。最近,增生性伴单克隆免疫球蛋白沉积的肾小球肾炎(PGNMID)纳入了该病的轻链变体(称为 PGNMID-LC)。有趣的是,除了单克隆轻链外,还发现肾小球共同沉积 C3,这意味着补体通过替代途径(AP)激活。我们介绍了一例独特的增生性 GN 病例,患者为 42 岁男性,表现为肾病综合征,并发现κ轻链多发性骨髓瘤。肾小球的免疫染色仅对κ轻链和 C3 呈阳性,电镜下可见明显的非淀粉样纤维。对骨髓瘤进行克隆靶向治疗后,肾脏临床异常完全缓解。我们对轻链和补体进行了详细的分子研究,并考虑了单克隆κ轻链纤维可能在肾小球内触发 AP 激活的局部机制。